The second task force will have the goal of developing guidelines for use of MRI technology in a trial setting, with the aim of supporting the eventual role of MRI as a true surrogate that might predict, in a brief period, long term clinical benefit. 1995, in press. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Compston DA, Emre M and the UK Tizanidine Study Group. Volmer T, Shellenberger MK and the US Tizanidine MS Study Group.
Evoked potentials predict the clinical changes in a multiple sclerosis drug study.
Sipe JC, Knobler RL, Braheny SL, Rice GP, Oldstone MB . Troiano R et al. Effect of total Iymphoid radiation in chronic progressive multiple sclerosis. Quantitative examination of neurologic function. Boca Raton, Florida.